DCF — KNAPP MEDICAL CENTER
Enterprise Value: $-31.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-31.0M
Enterprise Value
$-12.5M
PV of Cash Flows
$-18.5M
PV of Terminal Value
$-29.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $100.9M | $-0.4M | -0.0% | $-4.7M | $-4.3M |
| Year 2 | $103.9M | $0.6M | 1.0% | $-3.8M | $-3.1M |
| Year 3 | $107.0M | $1.7M | 2.0% | $-2.9M | $-2.1M |
| Year 4 | $110.2M | $2.3M | 2.0% | $-2.4M | $-1.6M |
| Year 5 | $113.5M | $2.6M | 2.0% | $-2.2M | $-1.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-31.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$97.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.009323213760114446
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5